Prosecution Insights
Last updated: October 25, 2026

SAMYANG Corporation

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

10 pending office actions • 7 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days

Analysis

SAMYANG Corporation has 10 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 10 distinct examiners across 7 distinct art units, indicating complete examiner dispersion and moderate concentration among technical units.

TRAN, LIEN THUY is the busiest examiner, with 1 pending matter. No examiner carries multiple active matters, so prosecution planning should focus on consistent portfolio positions while addressing each examination relationship separately.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

10
Total Pending OAs
7
Non-Final OAs
2
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
1
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (1)Due ≤ 30 days (1)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (30%)
4
Medium (40%)
3
Easy (30%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (20%)
§102 only1 (10%)
§112 only3 (30%)
Double-patenting + other1 (10%)
Multi-statute (no §101)3 (30%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

9
Life Sciences
90% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
10% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

100 h
Manual time on pending OAs
20 h
Time saved (low, 20%)
35 h
Time saved (mid, 35%)
0.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
TRAN, LIEN THUY 1 28.7% +26.5%
PRAKASH, SUBBALAKSHMI 1 45.6% +36.2%
BERRY, LAYLA D 1 66.0% +9.0%
REGLAS, GEORGIANA C 1 39.2% +33.4%
XU, JIANGTIAN 1 64.9% +35.5%
GRASER, JENNIFER E 1 76.8% +23.2%
CHO, DAVID H 1 31.9% +67.0%
NOAKES, SUZANNE MARIE 1 73.4% +18.3%
KOLB, KATARZYNA I 1 45.3% +17.2%
LEBLANC, KATHERINE DEGUIRE 1 34.6% +36.0%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
19103859 COATING COMPOSITION COMPRISING KESTOSE TRAN, LIEN THUY —
18765473 METHOD FOR PRODUCING FUNCTIONAL CRYSTALLINE SWEETENER BERRY, LAYLA D —
18265998 YEAST EXTRACT CONTAINING TRIPEPTIDE AND PREPARATION METHOD THEREFOR NOAKES, SUZANNE MARIE —

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18267867 DEXTRIN WITH IMPROVED TURBIDITY, AND METHOD FOR PRODUCING SAME CHO, DAVID H 30d overdue
17909196 POLYBUTYLENE TEREPHTHALATE RESIN COMPOSITION HAVING EXCELLENT FLAME RETARDANCY AND HYDROLYSIS RESISTANCE AND MOLDED ARTICLE PRODUCED THEREFROM KOLB, KATARZYNA I 16d
18270293 RECOMBINANT MICROORGANISM EXPRESSING FUCOSYLTRANSFERASE, AND METHOD OF PRODUCING 2'-FUCOSYLLACTOSE USING SAME GRASER, JENNIFER E 56d
19103859 COATING COMPOSITION COMPRISING KESTOSE TRAN, LIEN THUY —
18868910 ALLULOSE COMPOSITION WITH EXCELLENT STABILITY PRAKASH, SUBBALAKSHMI —
18722755 GLYCOSYLTRANSFERASE VARIANT, AND METHOD OF PREPARING STEVIOL GLYCOSIDES USING SAME REGLAS, GEORGIANA C —
18576160 HYDROXYPHENYL-TERMINATED POLYSILOXANE, POLYSILOXANE-POLYCARBONATE COPOLYMER COMPRISING THE SAME AS REPEATED UNIT WITH EXCELLENT TRANSPARENCY AND IMPROVED FLAME RETARDANCY, AND METHOD FOR PREPARING THE COPOLYMER XU, JIANGTIAN —
18265998 YEAST EXTRACT CONTAINING TRIPEPTIDE AND PREPARATION METHOD THEREFOR NOAKES, SUZANNE MARIE —

Top Art Units

Art UnitApps
1793 2
1693 2
1651 1
1645 1
1656 1
1767 1
1791 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19103859 COATING COMPOSITION COMPRISING KESTOSE TRAN, LIEN THUY 1793 §102§103§112 Non-Final OA — Pending Feb 14, 2025
18868910 ALLULOSE COMPOSITION WITH EXCELLENT STABILITY PRAKASH, SUBBALAKSHMI 1793 §103 Non-Final OA — Pending Nov 25, 2024
18765473 METHOD FOR PRODUCING FUNCTIONAL CRYSTALLINE SWEETENER BERRY, LAYLA D 1693 §102§112 Non-Final OA — Pending Jul 08, 2024
18722755 GLYCOSYLTRANSFERASE VARIANT, AND METHOD OF PREPARING STEVIOL GLYCOSIDES USING SAME REGLAS, GEORGIANA C 1651 §112DP Non-Final OA — Pending Jun 21, 2024
18576160 HYDROXYPHENYL-TERMINATED POLYSILOXANE, POLYSILOXANE-POLYCARBONATE COPOLYMER COMPRISING THE SAME AS REPEATED UNIT WITH EXCELLENT TRANSPARENCY AND IMPROVED FLAME RETARDANCY, AND METHOD FOR PREPARING THE COPOLYMER XU, JIANGTIAN — §102 Non-Final OA — Pending Jan 03, 2024
18270293 RECOMBINANT MICROORGANISM EXPRESSING FUCOSYLTRANSFERASE, AND METHOD OF PRODUCING 2'-FUCOSYLLACTOSE USING SAME GRASER, JENNIFER E 1645 §112 Final Rejection 56d Pending Jun 29, 2023
18267867 DEXTRIN WITH IMPROVED TURBIDITY, AND METHOD FOR PRODUCING SAME CHO, DAVID H 1693 §112 Final Rejection 30d overdue Pending Jun 16, 2023
18265998 YEAST EXTRACT CONTAINING TRIPEPTIDE AND PREPARATION METHOD THEREFOR NOAKES, SUZANNE MARIE 1656 §102§103§112 Non-Final OA — Pending Jun 08, 2023
17909196 POLYBUTYLENE TEREPHTHALATE RESIN COMPOSITION HAVING EXCELLENT FLAME RETARDANCY AND HYDROLYSIS RESISTANCE AND MOLDED ARTICLE PRODUCED THEREFROM KOLB, KATARZYNA I 1767 §103 Non-Final OA 16d Pending Sep 02, 2022
17255008 SWEETENER POWDER COMPOSITION AND PREPARATION METHOD THEREFOR LEBLANC, KATHERINE DEGUIRE 1791 §112 Non-Final OA — Pending Dec 22, 2020

Managing SAMYANG Corporation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does SAMYANG Corporation have?

SAMYANG Corporation has 10 pending office actions as of October 2026, spread across 7 art units and 10 examiners.

Which USPTO examiner handles the most SAMYANG Corporation applications?

Lien Thuy Tran has the most, with 1 of SAMYANG Corporation's pending office actions.

What technology area are SAMYANG Corporation's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month